Evaluation of the Educational Programs Effectiveness for the Prevention of Health Risk Factors and Anti-Doping Rule Violations Among the Younger Generation
- DOI
- 10.2991/aebmr.k.200114.205How to use a DOI?
- Keywords
- health risk factors, hygienic literacy, educational competences, educational programs, efficiency assessment
- Abstract
The article Antipova E., Badrak, K. and Antipov, V. “Evaluating the effectiveness of educational programs prevention of health and anti-doping rule risk factors violations among the younger generation” considers the problem of health risk factors primary prevention among children, adolescents and young adults and cases of doping in young athletes sports through the implementation of educational programs. The purpose of this study is to determine a unified approach to the development or selection of health risk factors prevention existing means, the starting position of which are the criteria for the effectiveness and evaluation of the educational program. The authors have developed educational preventive programs for schoolchildren and young athletes, defined the criteria for the effectiveness of these programs. The developments have been tested and put into practice. The evidence base allows us to speak about the reliability of the educational preventive programs effectiveness proposed assessment.
- Copyright
- © 2020, the Authors. Published by Atlantis Press.
- Open Access
- This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Cite this article
TY - CONF AU - E.V. Antipova AU - K.A. Badrak AU - V.A. Antipov PY - 2020 DA - 2020/01/18 TI - Evaluation of the Educational Programs Effectiveness for the Prevention of Health Risk Factors and Anti-Doping Rule Violations Among the Younger Generation BT - Proceedings of the First International Volga Region Conference on Economics, Humanities and Sports (FICEHS 2019) PB - Atlantis Press SP - 843 EP - 846 SN - 2352-5428 UR - https://doi.org/10.2991/aebmr.k.200114.205 DO - 10.2991/aebmr.k.200114.205 ID - Antipova2020 ER -